Daniel Aharoni is assistant professor of neurology at the University of California, Los Angeles (UCLA). He received his Ph.D. in physics from UCLA, where he worked in high- and low-energy particle physics before shifting his focus to neurophysics. Aharoni stayed at UCLA for a postdoctoral fellowship under Baljit Khakh, Alcino Silva and Peyman Golshani, spearheading the technical development of the open-source UCLA Miniscope Project. Aharoni’s lab integrates engineering, neuroscience and physics to create innovative tools that address complex challenges in neuroscience. His research aims to enhance our understanding of neural circuits, advance tool design for neuroscience, and ensure equitable access to pioneering technologies.
Daniel Aharoni
Assistant professor of neurology
University of California, Los Angeles
From this contributor
Designing an open-source microscope
Funding for the development of open-source tools is on the rise, but support for their maintenance and dissemination, both crucial for their meaningful uptake, remains a major challenge.
Designing an open-source microscope
By
Daniel Aharoni
17 June 2024 | 6 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read